Sunday, July 9, 2017

Pharma Reviews: GlaxoSmithKline Pharma to invest Rs 1000 crore in Karnataka plant

GlaxoSmithKline Pharma to invest Rs 1,000 crore in Karnataka plant ... at enhancing its global pipeline in areas like respiratory drugs and vaccines in India. "We are investing Rs 1,000 crore in a new state-of-the- art pharmaceutical ...
Read more: GlaxoSmithKline Pharma to invest Rs 1000 crore in Karnataka plant